“While higher medical costs in our stop loss product impacted fourth quarter earnings, we are taking corrective actions to address these near-term pressures and we are simultaneously taking steps to further advance our long-term growth strategy,” David Cordani, chairman and CEO of The Cigna Group, said.
Total revenues in the fourth quarter were $65.6 billion, up 28% year over year. Total revenues in 2024 were $247 billion, up 27%.
In the fourth quarter, net income was more than $1.4 billion, up 38%. Year-end net income was $3.4 billion, down 34% year over year.
Evernorth revenues rose 33% year over year to $53.7 billion in the fourth quarter. Operational earnings in the fourth quarter were $1.9 billion, and $5.6 billion in 2024.
The insurance side of the business, Cigna Healthcare, reported fourth quarter revenues of nearly $13.3 billion, up 3% from the previous year. Operational income in the fourth quarter was $468 million, and $4.4 billion in 2024.
The company’s medical loss ratio was 87.9% in the fourth quarter, compared to 82.2% during the same period last year. In 2024, the company’s MLR was 83.2%.
As of Dec. 31, Cigna had 19.1 million total medical members, down 3% year over year. There are 589,000 Medicare Advantage members, which are being sold to Health Care Service Corp. in the first quarter.
The company’s projected 2025 revenue is at least $252 billion. Full-year adjusted income from operations is projected to be at least $7.9 billion, or at least $29.50 per share.
